Mitsuhiko Moriyama Selected Research

Mitsuhiko Moriyama Research Topics

Disease

32	Hepatocellular Carcinoma (Hepatoma) 07/2022 - 04/2002
31	Infections 07/2022 - 12/2006
24	Chronic Hepatitis C 07/2021 - 11/2002
21	Liver Cirrhosis (Hepatic Cirrhosis) 11/2021 - 01/2003
18	Liver Diseases (Liver Disease) 05/2022 - 11/2001
17	Neoplasms (Cancer) 07/2022 - 12/2002
11	Chronic Hepatitis (Chronic Active Hepatitis) 11/2021 - 08/2002
9	Hepatitis 05/2022 - 08/2002
7	Fibrosis (Cirrhosis) 07/2022 - 08/2002
6	Hepatitis C 01/2009 - 06/2002
5	Stomach Neoplasms (Stomach Cancer) 02/2022 - 10/2008
5	Hepatitis B 10/2019 - 01/2003
4	Acute Liver Failure (Fulminant Hepatic Failure) 05/2022 - 01/2013
4	Liver Failure 06/2021 - 01/2003
4	Chronic Hepatitis B 02/2010 - 01/2003
3	Inflammation (Inflammations) 04/2020 - 09/2004
3	Autoimmune Hepatitis 02/2018 - 01/2004
3	Carcinogenesis 07/2016 - 12/2002
2	Pathologic Constriction (Stenosis) 10/2022 - 05/2018
2	Pancreatitis 10/2022 - 10/2017
2	Esophageal and Gastric Varices (Esophageal Varices) 01/2022 - 11/2014
2	Adenocarcinoma 12/2021 - 08/2020
2	Ascites 07/2021 - 07/2014
2	Obesity 03/2021 - 01/2019
2	Alcoholism (Alcohol Abuse) 03/2021 - 10/2019
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 09/2020 - 04/2020
2	Neoplasm Metastasis (Metastasis) 09/2020 - 10/2008
2	Ulcerative Colitis 09/2020 - 05/2010
2	Coinfection 11/2019 - 11/2001
2	Persistent Infection 10/2019 - 02/2007
2	Non-alcoholic Fatty Liver Disease 01/2019 - 07/2018
2	Hepatic Encephalopathy 07/2018 - 07/2014
2	Exanthema (Rash) 06/2018 - 01/2016
2	Alcoholic Fatty Liver 05/2018 - 01/2013
2	Virus Diseases (Viral Diseases) 01/2018 - 12/2006
2	Hemorrhage 02/2016 - 05/2015
2	Latent Tuberculosis 01/2016 - 01/2015
2	Tuberculosis (Tuberculoses) 01/2016 - 01/2015
2	Autoimmune Diseases (Autoimmune Disease) 01/2016 - 01/2004
2	Disease Progression 01/2013 - 12/2006
1	Necrosis 07/2022
1	COVID-19 07/2022

Drug/Important Bio-Agent (IBA)

21	InterferonsIBA 07/2022 - 01/2003
18	Antiviral Agents (Antivirals)IBA 07/2022 - 12/2002
10	RNA (Ribonucleic Acid)IBA 08/2020 - 11/2001
9	Proteins (Proteins, Gene)FDA Link 05/2022 - 09/2004
9	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 08/2002
6	ZincIBA 07/2021 - 11/2006
5	Hepatitis B Surface Antigens (HBsAg)FDA Link 11/2019 - 06/2002
4	CytokinesIBA 05/2022 - 01/2017
4	VaccinesIBA 01/2021 - 01/2018
4	Biomarkers (Surrogate Marker)IBA 07/2020 - 02/2007
4	Ribavirin (Virazole)FDA LinkGeneric 01/2016 - 06/2006
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2022 - 12/2002
3	Immune Checkpoint InhibitorsIBA 12/2021 - 09/2020
3	Pharmaceutical PreparationsIBA 07/2021 - 03/2016
3	Toll-Like Receptors (Toll-Like Receptor)IBA 07/2021 - 05/2020
3	SteroidsIBA 06/2021 - 01/2004
3	entecavir FDA Link 02/2010 - 09/2008
3	Interferon-alpha (Interferon Alfa)IBA 01/2009 - 01/2005
3	AntibodiesIBA 02/2007 - 04/2002
3	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2005 - 08/2002
2	lenvatinibIBA 07/2022 - 05/2020
2	Subgenomic RNAIBA 05/2022 - 02/2022
2	favipiravirIBA 05/2022 - 02/2022
2	NucleotidesIBA 02/2022 - 05/2004
2	Hepatitis A AntibodiesIBA 02/2022 - 12/2020
2	Bevacizumab (Avastin)FDA Link 12/2021 - 01/2021
2	atezolizumabIBA 12/2021 - 01/2021
2	NivolumabIBA 12/2021 - 09/2020
2	glecaprevir and pibrentasvirIBA 11/2021 - 07/2021
2	Alanine Transaminase (SGPT)IBA 11/2021 - 02/2005
2	zinc chloride FDA Link 07/2021 - 11/2020
2	Phosphotransferases (Kinase)IBA 05/2020 - 03/2019
2	Serum AlbuminIBA 02/2020 - 11/2012
2	NucleosidesIBA 10/2019 - 02/2009
2	IronIBA 05/2018 - 11/2002
2	SofosbuvirIBA 01/2018 - 01/2017
2	ledipasvirIBA 01/2018 - 01/2017
2	Indocyanine Green (Cardio-Green)FDA LinkGeneric 11/2017 - 05/2014
2	miriplatinIBA 07/2016 - 03/2016
2	Immunoglobulin G (IgG)IBA 01/2016 - 04/2009
2	Indicators and Reagents (Reagents)IBA 11/2012 - 08/2002
2	Amino Acids FDA Link 11/2012 - 12/2004
2	Lamivudine (Epivir)FDA Link 02/2010 - 09/2008
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 09/2009 - 01/2006
2	Immunoglobulins (Immunoglobulin)IBA 04/2009 - 12/2006
2	Fluorouracil (Carac)FDA LinkGeneric 10/2008 - 06/2006
2	AntigensIBA 01/2005 - 09/2004
1	LuciferasesIBA 05/2022
1	RNA-Dependent RNA Polymerase (RNA Dependent RNA Polymerase)IBA 05/2022
1	Suppressor of Cytokine Signaling ProteinsIBA 05/2022

Therapy/Procedure

32	Therapeutics 07/2022 - 01/2003
3	Catheters 10/2022 - 03/2016
3	Drug Therapy (Chemotherapy) 02/2019 - 02/2007
2	Aftercare (After-Treatment) 07/2022 - 01/2019
2	Liver Transplantation 05/2022 - 02/2016
2	Blood Transfusion (Blood Transfusions) 03/2019 - 02/2007
2	Retreatment 03/2018 - 01/2018
1	Stents 10/2022